Healthcare | May 05, 2026
OBESITAS 2026 concludes with focus on India’s rising obesity burden
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
